Logo-ia
ImmunoAnalysis. 2023;3: 7.
doi: 10.34172/ia.2023.07
  Abstract View: 331
  PDF Download: 297

Original Research

A Novel Multi-epitope Vaccine Against SARS-CoV-2 Variants of Concern Strains Applying Immunoinformatics Approaches

Samaneh Jahandar-Lashaki 1,2,3 ORCID logo, Safar Farajnia 2,4* ORCID logo, Morteza Milani 1, Mohammad Kazem Hosseini 4,5, Rana Yousefzadeh 6,7

1 Department of Medical Biotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
4 Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 Faculty of Sciences, Molecular Biology and Genetic, Istanbul University, Istanbul, Turkey
6 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
7 Central Medical Laboratory, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Author: Safar Farajnia, Email: farajnias@tbzmed.ac.ir

Abstract

Background: The newly emerged coronavirus, SARS-CoV-2, the causative agent of the COVID-19 disease, appeared in Wuhan, China in December 2019 and led to the death of millions of people. The pandemic has increased the demand for effective vaccines and treatments worldwide. Due to the changes in the virus genome caused by mutation, variants with higher transmission ability and pathogenicity have emerged and raised excessive concerns about the efficiency of the developed vaccines. This study aimed to design a multi-epitope vaccine that targets the primary SARS-CoV-2 strain and its five variants of concern using immunoinformatics approaches.

Methods: B-cell, cytotoxic T lymphocytes (CTLs) and helper T lymphocytes epitopes of the conserved and mutated SARS-CoV-2 surface glycoproteins were predicted using immunoinformatics approaches. These epitopes were attached utilizing appropriate linkers, and to provoke the immune response efficiently, the cholera toxin B subunit was added as an adjuvant.

Results: Analyses by different bioinformatics softwares revealed that the designed vaccine’s high safety, stability, and efficacy.

Conclusion: In this study, the vaccine designed by immunoinformatics tools showed specific reactivity to Toll-like receptor 4. Given the validation of other epitope-based vaccines, our vaccine might be capable of providing strong immunity in a wide range of populations.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 332

Your browser does not support the canvas element.


PDF Download: 297

Your browser does not support the canvas element.

Submitted: 07 Feb 2023
Revision: 27 Apr 2023
Accepted: 03 May 2023
ePublished: 28 Jun 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)